Targeting the plasmepsin 4 orthologs of Plasmodium sp. with "double drug" inhibitors

Linda Janka, Jose Clemente, N. Vaiana, A. Sparatore, Sergio Romeo, Ben M. Dunn

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Plasmepsin 4 (PM4) is a digestive vacuole enzyme found in all Plasmodium species examined to date. While P. falciparum has three additional aspartic proteinases in its digestive vacuole in addition to plasmepsin 4, other Plasmodium species have only PM4 in their digestive vacuole. Therefore, PM4 may be a good target for the development of an antimalarial drug. This study presents data obtained with PM4s from several Plasmodium species. Low nanomolar Ki values have been observed for all PM4s studied.

Original languageEnglish
Pages (from-to)868-873
Number of pages6
JournalProtein and Peptide Letters
Volume15
Issue number9
DOIs
StatePublished - Sep 2008
Externally publishedYes

Keywords

  • A combination of two molecular entities in one compound that kill a pathogen by two mechanisms
  • A word derived from plasmodium pepsin
  • Double drug
  • Plasmepsin
  • Proteolytic enzyme from the plasmodium species
  • Statine

Fingerprint

Dive into the research topics of 'Targeting the plasmepsin 4 orthologs of Plasmodium sp. with "double drug" inhibitors'. Together they form a unique fingerprint.

Cite this